A/Prof Natalie Hannan leads the Therapeutics Discovery and Vascular Function Group, within the broader Translational Obstetrics Group at the Mercy Hospital for Women, University of Melbourne. She is passionate about developing new approaches to combat major complication of pregnancy, especially preeclampsia. Natalie’s research is focused on developing therapeutic strategies that are safe in pregnancy and novel approaches to deliver therapies directly to the placenta. Her pre-clinical research has led to a number of exciting clinical trials both internationally and nationally, on which she remained integral to the as the lead laboratory scientist.
Natalie’s research has been recognized by the award of a prestigious NHMRC CDF Fellowship and she currently holds two NHMRC Project Grants (as CIA), a further three as Co-CI and further philanthropic and University funded support schemes. She has a strong research profile with over 78 peer-reviewed publications in international journals.
Natalie is the President of the Australian New Zealand Placental Research Association, and an executive member on The International Federation of Placental Associations (IFPA) executive committee.Natalie is well known for her engagement and passion to communicate her research to the public, she was selected as a Fresh Scientist and awarded a Young Tall Poppy award. As a VESKI Inspiring Women Fellow, Natalie is a staunch ambassador for Women in STEM and is involved in initiatives to reduce the gender inequity in STEM.